YD Bio Ltd (YDES) stock
YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW
$4.85+0.12 (+2.54%)
Close on Nov 18, 2026Market cap $343.33MP/E –Yield –
YD Bio operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
For fiscal 2025 it was -$5.27M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.27M | – |
| FY2024 | Dec 31, 2024 | -$1.46M | – |
| FY2023 | Dec 31, 2023 | -$9.85K | – |
See a number that looks wrong?